导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 41.52% | 236/967 |
| 近一周 | -5.18% | 1034/1046 |
| 近一月 | -8.99% | 997/1044 |
| 近一季 | -17.36% | 1017/1031 |
| 近半年 | -4.09% | 958/1005 |
| 近一年 | 33.38% | 296/962 |
| 近两年 | 24.94% | 555/878 |
| 近三年 | 36.71% | 170/778 |
| 成立以来 | 109.16% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
17.89% 36/1014 |
17.10% 28/1038 |
22.67% 516/1050 |
- - |
| 2024 | -11.44% 795/1011 |
-3.71% 516/960 |
-1.17% 387/983 |
4.36% 900/991 |
-10.82% 925/1011 |
| 2023 | 6.23% 38/952 |
8.15% 168/880 |
-1.65% 281/895 |
-1.92% 153/915 |
1.82% 70/952 |
| 2022 | -17.10% 226/867 |
-12.82% 171/773 |
2.24% 660/806 |
-12.67% 437/845 |
6.51% 148/867 |
| 2021 | -9.33% 480/740 |
-3.45% 280/580 |
27.40% 63/659 |
-14.59% 599/704 |
-13.71% 678/740 |
| 2020 | 79.71% 92/554 |
22.10% 5/419 |
44.01% 12/466 |
-0.05% 420/517 |
2.25% 473/554 |
| 2019 | 72.81% 28/410 |
32.99% 216/1146 |
4.02% 76/1228 |
17.94% 23/390 |
5.92% 312/410 |
| 2018 | -33.56% 257/349 |
- - |
-1.57% 107/990 |
-14.49% 938/1000 |
-21.38% 995/1080 |
| 2017 | 16.57% 94/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.05% 85/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 宝盈医疗健康沪港深股票A VS. () |